In today’s market, numerous treatments for psoriasis are readily available, but finding one that meets your specific needs can be a daunting task.
Fortunately, biologics such as Ilumya have emerged to aid many patients coping with various forms of psoriasis. Ilumya has been shown to alleviate the majority of psoriasis symptoms and enhance overall quality of life, making it a promising treatment option.
If you’re interested in learning more about Ilumya and how it can benefit your psoriasis, you’ve come to the right place. In this article, we’ll delve into its advantages and disadvantages to provide you with a comprehensive understanding of this treatment.
What is Ilumya?
Ilumya is a prescription medication designed to treat various forms of psoriasis. It can be administered through oral pills as part of systemic therapy or through injections.
Additionally, Ilumya can be delivered via phototherapy, which involves using ultraviolet light (UV) to treat psoriasis.
Benefits of Ilumya for Psoriasis Patitents
Ilumya offers several benefits for individuals with psoriasis, including:
- Effective symptom relief: Ilumya has been shown to significantly reduce the severity and frequency of psoriasis symptoms, including itching, scaling, and redness.
- Long-lasting results: Treatment with Ilumya can provide long-term relief, with some patients experiencing symptom improvement for up to six months or longer.
- Improved quality of life: By reducing psoriasis symptoms, Ilumya can improve patients’ overall quality of life, including their mental health and social functioning.
- Safe for long-term use: Clinical studies have demonstrated that Ilumya is safe and effective for long-term use in individuals with psoriasis.
The benefits of Ilumya may vary depending on the individual and their specific case of psoriasis.
Ilumya for Psoriasis Treatment: Administration and Patient Profile
Ilumya injection is a treatment method specifically designed for patients with moderate to severe psoriasis who have not responded to other treatments. Here is an overview of how the injection is administered and the type of patient profile it is suitable for:
- Administration: Ilumya injections are administered subcutaneously, which means they are injected just below the skin. A healthcare provider usually administers the injection in a clinic or hospital setting.
- Patient profile: Ilumya injections are typically recommended for patients who have moderate to severe psoriasis and have not responded to other treatments, such as topical creams or light therapy. Patients who are candidates for Ilumya injections should have a confirmed diagnosis of psoriasis, be at least 18 years old, and not have a history of allergic reactions to any of the ingredients in Ilumya.
- Dosage and frequency: The dosage and frequency of Ilumya injections will be determined by a healthcare provider based on the patient’s individual condition and response to treatment. The initial dosing is two injections, given 4 weeks apart, followed by one injection every 12 weeks.
- Effectiveness: Ilumya injections work by targeting a specific protein in the body called interleukin-23 (IL-23), which is involved in the development of psoriasis. By blocking IL-23, Ilumya reduces inflammation and improves psoriasis symptoms. Patients typically see improvements in their psoriasis symptoms after several weeks of treatment with Ilumya.
Ilumya injections can be an effective treatment option for psoriasis, they may not be suitable for everyone. Regular follow-up appointments with a healthcare provider are important to monitor the effectiveness of Ilumya and to manage any potential side effects.
Precautions to Consider for Psoriasis Patients Taking Ilumya
While Ilumya is generally safe and effective for most patients, there are some cautions that psoriasis patients should be aware of when using this medication. These include:
- Infections: Ilumya can increase the risk of infections, including serious infections like tuberculosis. Patients should inform their healthcare provider if they have any signs of infection, such as fever or flu-like symptoms, while taking Ilumya.
- Allergic reactions: Some patients may experience allergic reactions to Ilumya, which can be serious. Symptoms of an allergic reaction can include hives, difficulty breathing, and swelling of the face, lips, or tongue. Patients should seek immediate medical attention if they experience any of these symptoms.
- Vaccinations: Patients should talk to their healthcare provider before receiving any vaccinations while taking Ilumya, as the medication can affect the effectiveness of certain vaccines.
- Pregnancy and breastfeeding: It is not known if Ilumya is safe for use during pregnancy or while breastfeeding. Patients should inform their healthcare provider if they are pregnant or breastfeeding or plan to become pregnant while taking Ilumya.
- Pre-existing medical conditions: Patients with certain pre-existing medical conditions, such as Crohn’s disease or ulcerative colitis, may be at increased risk for certain side effects of Ilumya. Patients should inform their healthcare provider of any pre-existing medical conditions before starting treatment with Ilumya.
It is important for patients to discuss any concerns or questions they have with their healthcare provider before starting treatment with Ilumya. Regular monitoring and follow-up with a healthcare provider is important to ensure the medication is safe and effective for the patient.
Side Effects of Ilumya for Psoriasis Patients
Ilumya is generally well-tolerated by most patients, but like any medication, it may cause side effects. Some common side effects of Ilumya for psoriasis patients may include:
- Upper respiratory infections
- Injection site reactions
Less common but more serious side effects may include:
- Allergic reactions
- Serious infections, such as tuberculosis or sepsis
- Inflammatory bowel disease
- Worsening of heart failure symptoms in patients with pre-existing heart failure
- Development of new or worsening nervous system problems, such as multiple sclerosis
Patients need to be aware of these potential side effects and to inform their healthcare provider if they experience any of them while taking Ilumya. Patients should also inform their healthcare provider of any other medications or supplements they are taking, as these may interact with Ilumya and increase the risk of side effects.
In some cases, the benefits of using Ilumya may outweigh the potential risks of side effects. Patients need to evaluate closely with their healthcare provider to determine if Ilumya is the right treatment option for their specific case of psoriasis.
How effective is Ilumya for psoriasis?
Ilumya showed significant improvement in psoriatic arthritis symptoms with 79.5% of patients experiencing a 20% improvement in ACR20 at week 24 compared to 50.6% on placebo.
What is ilumya psoriasis treatment?
Ilumya is a prescription medication for adults with moderate to severe plaque psoriasis who are eligible for systemic or phototherapy.
What is the cost of Ilumya?
Ilumya subcutaneous solution (100 mg/mL) costs approximately $17,296 for 1 milliliter(s), and prices may vary depending on the pharmacy. This cost is for cash-paying customers and is not applicable to those with insurance plans.
Is ilumya covered by insurance?
Through the Early Access Program, most individuals with commercial insurance can receive ILUMYA® for free during their first two years of treatment. After that, they may continue to pay very little or nothing for each dose. Additional assistance programs are also available to those who need help paying for their prescription.
Can you drink alcohol with Ilumya?
While it is generally safe to drink alcohol during Ilumya treatment, alcohol consumption can increase the risk of diarrhea, which is also a side effect of the medication. Therefore, alcohol consumption may exacerbate any diarrhea symptoms experienced while undergoing treatment with Ilumya.
Does Ilumya lower your immune system?
ILUMYA can suppress the immune system and increase the risk of infection.
How long does it take for Ilumya to work?
Ilumya (tildrakizumab) typically takes 12 weeks to begin working, and nearly 60% of patients experience a 75% reduction in psoriasis severity during this period. However, it may take more than a year for patients to realize the medication’s full benefits.